Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Stomach Neoplasms 3Melanoma 2Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Locally Advanced Colorectal Cancer 1HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma 1Gastric Adenocarcinoma 1Colorectal Cancer Metastatic 1Breast Neoplasms 1Advanced Gastric Cancer 1

Interventions

Fluorouracil 8Bevacizumab 8Oxaliplatin 7Leucovorin 7Irinotecan 7Capecitabine 7Cetuximab 6Panitumumab 4sintilimab 2regorafenib 2aflibercept 2tremelimumab 1spartalizumab 1pembrolizumab 1irinotecan sucrosofate 1durvalumab 1camrelizumab 1atezolizumab 1anisodamine 1SHR-1701 1Radiotherapy 1Pemetrexed 1Nivolumab 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methotrexate 1Lycopene 1Loperamide 1Ipilimumab 1HMPL-013 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Colorectal Cancer Metastatic × SHR-1701 × Clear all
NCT06679673 2024-11-07

SHR-1701 Combined with SHR2554 and BP102 for MCRC

Fudan University

Phase 2 Not yet recruiting
20 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡